# GPT-5.4 (R2) Review

**Role:** External referee review
**Model:** openai/gpt-5.4
**Paper:** paper.pdf
**Timestamp:** 2026-03-26T13:05:56.912010
**Route:** OpenRouter + LaTeX
**Review mode:** Tri-model (3 independent reviewers)
**Tokens:** 13281 in / 5457 out
**Response SHA256:** d45754d5e0934ffe

---

This paper asks an important and potentially high-impact question: whether a change in enforcement architecture—here, the Illinois Supreme Court’s 2019 *Rosenbach* decision interpreting BIPA—had real labor-market effects in industries differentially exposed to biometric litigation risk. The topic is timely, the legal shock is substantively important, and the paper’s central intuition is plausible. The attempt to move beyond a binary treated/untreated industry split toward a continuous exposure design is also potentially valuable.

That said, in its current form the paper is not publication-ready for a top general-interest journal or AEJ: Economic Policy. The core problem is that the empirical design and inference do not yet support the strength of the paper’s causal claims. The paper is transparent about some weaknesses—notably the 2018 pre-trend and the six-state inference problem—but the current fixes are not sufficient. At present, the evidence is suggestive rather than persuasive.

## 1. Identification and empirical design

### A. The identification strategy is conceptually attractive but currently not fully credible

The main specification is a continuous-exposure DDD:
\[
\log Y_{ijt} = \beta (\text{IL}_i \times \text{Post}_t \times \text{Exposure}_j) + \gamma_{ij} + \delta_t + \text{lower-order terms} + \varepsilon_{ijt}
\]
with county-sector fixed effects and quarter fixed effects (Section 4).

The causal interpretation requires a strong parallel-trends-type assumption: absent *Rosenbach*, higher-exposure sectors in Illinois border counties would have evolved similarly to higher-exposure sectors in neighboring-state border counties, relative to lower-exposure sectors. This assumption is only partly articulated and not convincingly demonstrated.

The biggest identification concerns are:

#### (i) Nontrivial pre-trends / anticipatory dynamics
The paper acknowledges a “localized positive bump” in 2018 in the event study (Section 6; Figure 1) and reports a placebo effect when assigning treatment to 2017Q1 of +6.5% with \(p=0.022\) (Table 3). That is not a minor issue. A statistically meaningful placebo in the pre-period directly weakens the identifying assumption.

The manuscript argues that this is “not a smooth secular trend” and therefore that dropping 2017–2018 is the “more diagnostic” solution (Section 6). I do not find that persuasive enough. If the 2018 deviation reflects anticipation, legal uncertainty, composition changes, or other confounders, then treatment timing is itself fuzzy and the clean break at 2019Q1 becomes less sharp. If it reflects unrelated shocks differentially affecting Illinois high-exposure sectors, then the design remains vulnerable. Either way, the paper needs a stronger account of what exactly happened in 2018 and why the trimmed-window approach recovers the correct counterfactual.

Moreover, the fact that adding an Illinois × exposure linear trend flips the estimate positive and insignificant (\(+0.063\), \(p=0.162\); Table 3) is not dispositive either way, but it shows meaningful fragility. The manuscript dismisses that result as mechanical overcorrection; perhaps, but that remains an assertion rather than a demonstration.

#### (ii) Border-county design does not cleanly isolate cross-border adjustment
The border-county focus is intuitive, but the paper’s own mechanism evidence cuts against the relocation/regulatory-competition interpretation. Section 7 reports that neighboring-state border counties also experience a negative coefficient (\(-8.2\%\), \(p=0.005\)) rather than mirror-image gains. This is a major fact, not a side note. If both Illinois border counties and neighboring border counties decline in more exposed sectors, the identifying contrast may be contaminated by broader regional shocks hitting border-area exposed sectors around the same time.

The paper reframes this by saying the border design identifies places “more exposed to regulatory competition, not necessarily because firms physically moved.” But once the neighboring controls show similar directional declines, the border design no longer obviously sharpens identification; it may instead select a peculiar regional sample with correlated sectoral shocks.

At minimum, this result substantially weakens the interpretation that the large border estimate reflects BIPA-induced cross-state adjustment.

#### (iii) Exposure measure may be only loosely tied to actual litigation risk
The exposure index is innovative, but its connection to realized BIPA exposure remains uncertain. The paper itself notes that Administrative Services has very high measured exposure (0.97) but shows essentially no effect (Table 2; Section 6; Appendix on exposure sensitivity). That is not a small annoyance: it raises concern that the treatment intensity measure is misaligned with the legal/economic object of interest.

This problem is compounded by the fact that the index is built from O*NET version 29.1 released in March 2025 (Section 3; Appendix), i.e. after the treatment period. The paper argues that occupational content changes slowly and is not endogenous to Illinois litigation risk. That may be directionally true, but using a post-period measure to characterize pre-2019 exposure is still uncomfortable, especially when the underlying technology adoption of biometrics plausibly changed sharply during 2019–2024. A “structural” argument is not enough without more validation.

More broadly, the index appears to mix workplace biometric use and consumer-facing biometric use, while much of the BIPA litigation wave involved the latter. Section 7 acknowledges this, but this acknowledgment also limits the interpretation of \(\beta\): it may capture some diffuse technology intensity rather than expected BIPA liability per se.

#### (iv) Potential sample-selection issues from suppressed QCEW cells
Section 3 and the Data Appendix state that disclosure-suppressed cells and zero/negative employment cells are dropped. In a county × sector × quarter panel with smaller sectors (e.g., Management), suppression may be nonrandom and plausibly affected by treatment if employment falls below reporting thresholds. That creates a selection issue, especially because some of the most dramatic effects appear in sectors with relatively few observations (e.g., Management in Table 2).

The paper does not analyze whether treatment changes the probability that a cell is observed. This is a potentially important threat to identification.

### B. Treatment timing is coherent, but the “single discrete shock” framing is too strong
The paper repeatedly characterizes *Rosenbach* as a sharp judicial shock (Introduction; Conclusion). That framing is reasonable as a first pass but somewhat overstated given the paper’s own evidence:

- oral arguments occurred in May 2018 (Section 6),
- there is a significant pre-period placebo,
- post-treatment effects widen over several years, consistent with a gradual litigation/settlement process.

This looks more like a legally salient shock with possible anticipation and delayed transmission than a textbook sudden treatment onset. The paper should calibrate the timing claim accordingly and test timing robustness more systematically.

## 2. Inference and statistical validity

This is the most serious barrier to publication in current form.

### A. Main inference is not reliable with six state clusters
The paper clusters standard errors at the state level throughout (Section 4; Tables 1–3). But there are only six states total, with effectively one treated state and five controls. The manuscript explicitly acknowledges that “with six state clusters, asymptotic inference is unreliable” (Section 4).

That acknowledgment is correct, and it has major implications. The conventional clustered p-values in Tables 1–3 should not be treated as decisive evidence. Yet the paper continues to foreground them in the abstract, introduction, results, and conclusion. That is not acceptable for a top-journal standard of inference.

The randomization inference results are much weaker than the conventional p-values:

- state permutation RI: \(p=0.167\),
- timing permutation RI: \(p=0.077\)
(Table 3; Identification Appendix).

These are, in my view, the more relevant inferential statistics here. Under the state-permutation exercise, the effect is not conventionally significant. The paper notes that \(1/6\) is the minimum achievable p-value, but that does not rescue the claim. It means the design has intrinsically limited leverage for sharp state-level inference.

The current draft presents the conventional state-clustered p-values as primary and RI as a robustness check. Given the design, that ordering should be reversed.

### B. Sector-specific inference is especially weak
Table 2 reports separate sector-by-sector DiD regressions, each with standard errors clustered at the state level. This is very hard to justify statistically. Once the sample is split by sector, the effective identifying variation is still state-by-time, but now with even less information. Claims such as “Management (\(-34.4\%\), \(p=0.046\))” or “Professional Services (\(-7.1\%\), \(p=0.034\))” are far too precise-looking relative to the actual inferential leverage.

These p-values are not credible enough to support the text’s strong claims about which sectors were and were not affected.

### C. The paper needs better finite-sample inference
At minimum, the paper should implement and foreground methods appropriate for few treated clusters / cluster-randomized-like settings. Depending on the exact estimand and sampling structure, plausible tools include:

- wild cluster bootstrap-t procedures,
- randomization/permutation inference designed around the actual treatment assignment problem,
- aggregate-state or border-pair level collapsing as a check,
- possibly inference based on a more transparent state × sector × quarter panel.

Even these may have limited power with one treated state, but that limitation should be embraced rather than masked by conventional clustered SEs.

### D. Sample sizes are reported, but coherence issues remain
Observation counts are mostly reported clearly, though there are small discrepancies (e.g., 19,737 raw border observations vs. 19,726 in regressions; this is explained by singleton removal). That part is fine.

However, because suppression and positive-employment restrictions may induce endogenous panel composition, the paper needs additional reporting on balancedness and cell attrition by treatment exposure.

## 3. Robustness and alternative explanations

### A. Existing robustness checks are useful but not yet sufficient
The paper includes several sensible checks: trimmed pre-period, pre-COVID sample, sector × quarter FE, leave-one-state-out, placebo timing, RI, and alternative exposure constructions (Section 6; Table 3). This is a good start.

However, several robustness exercises are not interpreted with enough discipline:

#### (i) Excluding Administrative Services strengthens the effect dramatically
Dropping Administrative Services changes the estimate from \(-11.7\%\) to \(-19.8\%\) (Table 3). The paper interprets this as showing the baseline is conservative because Admin Services is “high O*NET/low-litigation.” But this also reveals substantial dependence on how the exposure measure maps into sectors. One could read this either as improved treatment measurement or as ex post pruning of an inconvenient high-exposure null sector. The current discussion is too one-sided.

#### (ii) Pre-COVID restriction helps, but does not settle identification
The pre-COVID estimate of \(-4.5\%\) (\(p=0.034\)) is reassuring directionally. But with the same six-cluster problem, that p-value should not be over-interpreted. Also, if the main post-2019 effect grows over time as litigation risk accumulates, the smaller pre-COVID effect is consistent with many stories, not uniquely the paper’s preferred one.

#### (iii) “Simple DiD is null” is not very informative
The null simple DiD without industry variation (Table 3) is presented as supportive because treatment should operate through exposure heterogeneity. Perhaps. But it also shows that the aggregate Illinois-border labor market does not move strongly relative to neighbors, which may suggest reallocation within Illinois or noisy sector-level composition effects. This result should be treated more neutrally.

### B. Alternative explanations remain under-addressed

#### (i) Regional sector-specific shocks
Given the negative estimate in neighboring border counties and the 2018 pre-trend, the most important unresolved alternative explanation is that exposed sectors in the Illinois-border region were already on a different trajectory for reasons unrelated to BIPA. The current controls do not fully rule this out.

I would especially want to see more geographically granular controls or specifications that exploit border-pair comparisons. For example, county-pair × quarter or border-segment × sector structures might better isolate local labor market shocks, though with tradeoffs in power.

#### (ii) Exposure correlated with secular technology/remote-work trends
The highest-exposure sectors—Information, Professional Services, Management—are precisely those undergoing major secular changes over 2019–2024, including remote work, platform reorganization, and pandemic-era restructuring. Sector × quarter FE absorb national sector shocks, but if Illinois-border exposed sectors differ from neighboring-state exposed sectors in pre-existing ways, the concern remains. The paper needs more direct evidence that the exposure index is not proxying for differential local adoption of remote-work-compatible or tech-intensive industries.

#### (iii) Broader legal/regulatory environment
The paper would benefit from clearer discussion of other Illinois-specific legal, tax, or labor-market developments around 2018–2024 that may differentially affect high-exposure sectors. The DDD design helps, but it does not immunize against state-specific shocks correlated with exposure.

### C. Mechanism claims are generally cautious, which is good
Section 7 is appropriately restrained in stating that the data cannot distinguish reduced hiring, organizational change, technology substitution, or relocation. This is one of the paper’s strengths. The manuscript is careful, for the most part, not to over-claim a specific mechanism.

That said, some language elsewhere goes beyond what is shown—for example, references to a “litigation tax” reshaping firm organization and location decisions. Those are plausible interpretations, but this paper does not directly observe them.

## 4. Contribution and literature positioning

The topic is potentially important and likely publishable in principle if the empirical design can be made more convincing. The contribution is strongest as evidence on how enforcement design—not only statutory text—can affect economic outcomes.

However, the literature positioning currently feels somewhat underdeveloped in two ways.

### A. Need tighter integration with causal design literature
Although this is not staggered adoption DiD, the paper is fundamentally a difference-in-differences/triple-difference design with treatment-intensity heterogeneity and few treated clusters. The econometric framing would benefit from engagement with the modern DiD/event-study literature on pre-trends, treatment timing, and inference. At a minimum, the paper should discuss how its assumptions relate to current best practice in DiD with heterogeneous exposure.

Concrete citations to consider:
- Bertrand, Duflo, and Mullainathan (2004) on DiD inference issues.
- Roth (2022) on pre-test problems / pre-trends.
- MacKinnon and Webb papers on few-cluster inference and wild bootstrap.
- Conley and Taber (2011) on inference with one treated policy unit.
- Ferman and Pinto (2019) or related work on inference with few treated groups.

These are important because the current inferential weakness is central to the paper’s contribution.

### B. Need fuller positioning in privacy/regulation/BIPA-specific empirical work
The current privacy citations are fairly broad (e.g., Miller and Tucker; Acquisti et al.). But the paper would benefit from a more precise account of existing work on biometric privacy laws, private rights of action, class-action enforcement, and state privacy regimes. If there is little directly causal evidence on BIPA, that itself should be highlighted and documented more concretely.

Similarly, the paper should better distinguish itself from work on employment effects of legal liability / labor regulation / business regulation. The current comparison to wrongful discharge laws and French thresholds (Section 8) is useful but somewhat distant from the exact institutional mechanism here.

## 5. Results interpretation and claim calibration

### A. The main conclusions currently overstate what the evidence establishes
The abstract and conclusion are too strong relative to the paper’s actual inferential footing. Statements such as:

- “I find that a one-unit increase in biometric litigation exposure reduced employment by 11.7%...”
- “demonstrating that enforcement architecture, not statutory text, determines the economic incidence of regulation”
- “a single judicial ruling transformed a dormant privacy statute into an active enforcement regime, generating employment declines...”

are too definitive.

A more accurate summary would be that the paper finds evidence consistent with employment declines concentrated in more exposed Illinois border industries after *Rosenbach*, but the magnitude is sensitive to pre-trend handling and statistical significance weakens substantially under design-appropriate randomization inference.

### B. Magnitudes need more discipline
The “one-unit increase” interpretation is somewhat awkward because the exposure scale is researcher-constructed and runs from 0 to 1 across only nine broad sectors. Interpreting \(-0.117\) as moving from Accommodation to Information is fine mechanically, but the paper sometimes slides from that comparison into broader statements about “biometric litigation exposure” more generally. Given the index’s imperfect validation, the practical meaning of a one-unit change should be discussed more cautiously.

### C. Policy implications should be scaled back
The concluding policy lesson—that enforcement design is a first-order policy lever—is plausible and potentially important. But the paper cannot yet support strong out-of-sample claims such as what “states can expect” when they adopt private rights of action (Section 8). This is a single-state setting with a specific statute, unusually high statutory damages, intense class-action activity, and a unique legal environment.

External validity should therefore be bounded more explicitly:
- Illinois is an extreme case.
- BIPA’s damages structure is unusually potent.
- the border-county result does not generalize automatically to statewide effects.
- the all-counties estimate is small and insignificant.

## 6. Actionable revision requests

### 1. Must-fix issues before acceptance

#### 1. Rebuild the inference strategy around few-treated-unit credibility
- **Issue:** Conventional state-clustered SEs with six states are not reliable, and RI does not show strong significance.
- **Why it matters:** Valid inference is non-negotiable. As currently written, the paper’s strongest claims rest on weakly justified p-values.
- **Concrete fix:** Make design-appropriate inference primary, not secondary. Implement and report wild cluster bootstrap and/or Conley-Taber-style inference where appropriate; present permutation/randomization inference as the main inferential framework; collapse to a state × sector × quarter or border-pair × sector × quarter panel as a check; rewrite the abstract and conclusions to reflect those results.

#### 2. Address the pre-trend/anticipation problem more convincingly
- **Issue:** The event study and placebo timing test show meaningful pre-treatment instability.
- **Why it matters:** This directly threatens the causal interpretation.
- **Concrete fix:** Provide a deeper timing analysis: alternative treatment dates, anticipation windows, binned event study, formal pre-trend tests with low-power caveats, and institutional evidence on litigation/press/oral-argument timing. Consider defining treatment as beginning in 2018Q2/Q3 if anticipation is credible, or explicitly estimating a fuzzy/transition period rather than a sharp break.

#### 3. Strengthen the geographic identification design
- **Issue:** Negative estimates in neighboring border counties undermine the clean control-group story.
- **Why it matters:** This suggests broader regional shocks or imperfect control validity.
- **Concrete fix:** Re-estimate using more local comparisons, such as matched county-pair or border-segment designs; include border-pair × time controls if feasible; show pre-period similarity for Illinois and adjacent non-Illinois counties within border segments; explore whether effects vary by distance to border in a way consistent with the proposed mechanism.

#### 4. Validate the exposure measure much more rigorously
- **Issue:** The 2025 O*NET-based index is only imperfectly mapped to realized BIPA exposure.
- **Why it matters:** The main treatment intensity variable is the backbone of the paper.
- **Concrete fix:** Bring in external validation data: actual BIPA case filings by industry, settlement data, Lexis/Westlaw case counts, or firm-level mentions of biometric systems. Show that the exposure index predicts pre- or post-*Rosenbach* litigation incidence across sectors. Report results using alternative exposure measures based directly on observed lawsuits.

#### 5. Investigate selection from suppressed/missing QCEW cells
- **Issue:** Dropping suppressed or zero-employment cells may create treatment-correlated sample selection.
- **Why it matters:** Apparent employment effects may partly reflect changing observability.
- **Concrete fix:** Report missingness/suppression rates by state, sector, and period; estimate whether treatment predicts cell presence; provide robustness using balanced panels and/or bounds.

### 2. High-value improvements

#### 6. Recast sector-specific results as descriptive heterogeneity, not firm evidence
- **Issue:** Table 2 p-values are too strong for the available inferential leverage.
- **Why it matters:** Current text overstates precision about which sectors were affected.
- **Concrete fix:** De-emphasize sector-by-sector hypothesis testing. Present these estimates as descriptive patterns, preferably with multiple-testing caution and few-cluster caveats.

#### 7. Clarify the estimand and practical meaning of exposure variation
- **Issue:** A “one-unit” increase in exposure is hard to interpret economically.
- **Why it matters:** This affects both magnitude interpretation and policy relevance.
- **Concrete fix:** Standardize effects in terms of interquartile exposure differences or concrete sector comparisons; show the distribution of exposure values; report semi-parametric specifications (e.g., terciles/quartiles of exposure) to demonstrate that results are not driven by one or two sectors.

#### 8. Probe alternative confounds in tech-intensive sectors
- **Issue:** Exposure may proxy for broader sectoral changes unrelated to BIPA.
- **Why it matters:** This is a plausible alternative explanation.
- **Concrete fix:** Interact post-2019 with sector characteristics such as teleworkability, IT intensity, or digital intensity; show that the biometric-exposure result survives controlling for these. If possible, compare to placebo states with similar tech-sector composition.

#### 9. Improve transparency around county and sector composition
- **Issue:** Some sectors have sparse county coverage (Table 2; Summary Statistics).
- **Why it matters:** Results may be driven by a narrow subset of cells.
- **Concrete fix:** Report balancedness, county counts by sector over time, and leverage diagnostics showing which sector-state-quarter cells contribute most to the estimate.

### 3. Optional polish

#### 10. Tone down “demonstrates” language throughout
- **Issue:** Claims outrun evidence.
- **Why it matters:** Better calibration will improve credibility.
- **Concrete fix:** Replace definitive causal wording with more measured formulations unless the revised inferential strategy supports stronger language.

#### 11. Narrow and sharpen the policy extrapolation
- **Issue:** The discussion of the “twenty-state privacy wave” is broader than the evidence.
- **Why it matters:** Over-generalization may alienate readers.
- **Concrete fix:** Frame Illinois as an informative upper-bound or salient case study, not a universal template.

## 7. Overall assessment

### Key strengths
- Important and policy-relevant question.
- Institutionally interesting legal shock.
- Creative continuous-exposure DDD design.
- Generally thoughtful discussion of mechanisms and limitations.
- Strong instinct to compare border and all-county samples and to acknowledge weaknesses rather than ignore them.

### Critical weaknesses
- Inference is currently inadequate for the design.
- Pre-treatment instability materially weakens identification.
- Control-group validity is undercut by negative effects in neighboring border counties.
- Exposure measure is not sufficiently validated against actual litigation risk.
- Core claims are overstated relative to what the current evidence can support.

### Publishability after revision
I think this paper is potentially salvageable and could become a serious contribution, but only after substantial redesign and reframing. The central idea is strong enough to merit another round, but not in its current form. To reach publishable quality, the paper needs a more convincing inferential strategy, stronger exposure validation, and a more disciplined causal narrative.

DECISION: MAJOR REVISION